N-acetylcysteine, an antioxidant with anti-adipogenic effect on adipocytes

Reports about antioxidant effect in obesity are contradictory. We showed that N-acetylcysteine (NAC) inhibits cellular lipid accumulation during adipocyte differentiation, through the inhibition of adipogenic transcriptor factors expression, such as PPARγ and, MAPKs phosphorylation (Pieralisi et al,...

ver descrição completa

Detalhes bibliográficos
Autores: Pieralisi, Azul, Soto, Daniela, Gabrielli, Matias, Martini, Claudia Noemí, Diz, Virginia Emilse, Rovner, Federico, Vila, Maria del Carmen, Calvo, Juan Carlos, Guerra, Liliana Noemi
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:Argentina
Recursos:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/56080
Acesso em linha:http://hdl.handle.net/11336/56080
Access Level:acceso abierto
Palavra-chave:Obesity
Antioxidant
Adipocyte
https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
Descrição
Resumo:Reports about antioxidant effect in obesity are contradictory. We showed that N-acetylcysteine (NAC) inhibits cellular lipid accumulation during adipocyte differentiation, through the inhibition of adipogenic transcriptor factors expression, such as PPARγ and, MAPKs phosphorylation (Pieralisi et al,Redox Biol 2016; Soto el al,Redox Rep 2016). Here we evaluated NAC on fully differentiated cells (3T3-L1 adipocytes: AC). Treatments with 0.01 to 5 mM NAC, included in culture media for 5 days, were not toxic. 5mM NAC treatment on AC (ACN) provoked a decrease of 60% in cellular Triglycerides (Tg) content (1.22+0.09 gTg/g protein [AC] vs 0.49+0.03 gTg/g protein [ACN], p<0.05). We evaluated Oil-Red-O stained lipids content in ACN comparing to AC, which is set to 100 (100+4 [AC] vs 80+2 [ACN] arbitrary units (AU), p< 0.05), lipid protein perilipin (Pl) mRNA levels (Pl/ Rplp0:100+13 [AC] vs 72+9 [ACN] AU, p< 0.05) and PPARγ: protein expression (PPARγ/GAPDH:100+6 [AC] vs 70+4 [ACN]AU; p< 0.05) and mRNA levels (PPARγ/Rplp0:100+7 [AC] vs 74+14 [ACN]AU, p<0.05). These NAC treatments produced a decrease of 20 ? 30%, suggesting that NAC could inhibit new lipid production. We developed liposome of 100nm diameter (LIP) including 5mM NAC, as better tool for NAC administration. Phase transition enthalpy decreased from 3.86 J/g in LIP to 3.25 J/g in LIP+NAC, indicating NAC incorporation.